{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "59-year-old female with a history of asbestos exposure presented on February 11, 2017, with abdominal distension and weakness. Imaging revealed cirrhosis, splenomegaly, portal hypertension, and peritoneal effusion on February 11, 2017. Tumor indicators showed no obvious abnormalities on February 13, 2017. Abdominal effusion revealed shed cancer cells. Imaging diagnosis indicated a large amount of ascites.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0009375",
              "label": "Cirrhosis",
              "status": "active",
              "onset_date": "2017-02-11"
            },
            {
              "code": "C0038968",
              "label": "Splenomegaly",
              "status": "active",
              "onset_date": "2017-02-11"
            },
            {
              "code": "C0032624",
              "label": "Portal Hypertension",
              "status": "active",
              "onset_date": "2017-02-11"
            },
            {
              "code": "C0004581",
              "label": "Ascites",
              "status": "active",
              "onset_date": "2017-02-11"
            }
          ],
          "HPI": [
            {
              "summary": "Patient presented with abdominal distension and weakness.",
              "onset": "2017-02-11"
            }
          ],
          "social_history": [
            {
              "category": "exposure",
              "status": "past",
              "description": "history of asbestos exposure"
            }
          ],
          "imaging": [
            {
              "type": "imaging",
              "body_part": "abdomen",
              "modality": "unknown",
              "finding": "cirrhosis, splenomegaly, portal hypertension, and peritoneal effusion",
              "impression": "large amount of ascites",
              "date": "2017-02-11"
            }
          ],
          "labs": [
            {
              "test": "Tumor indicators",
              "value": "no obvious abnormalities",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": "2017-02-13"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "On March 22, 2017, abdominal mesentery was slightly thickened. Laparoscopic peritoneal biopsy was performed, and hematoxylin and eosin staining revealed heterogeneous cell nests in the parietal peritoneal fiber tissue accompanied by degeneration. Immunohistochemical findings were Calretinin (+), WT-1 (\u00b1), and D2-40 (+), suggesting malignant mesothelioma. CDX-2 (\u2212) excluded tumors from the digestive tract, and ER (\u2212) excluded breast metastases. Patient diagnosed with malignant mesothelioma.",
        "timestamp": "2017-03",
        "clinical_data": {
          "imaging": [
            {
              "body_part": "abdominal mesentery",
              "finding": "slightly thickened",
              "date": "2017-03-22"
            }
          ],
          "procedures": [
            {
              "name": "Biopsy of peritoneum",
              "approach": "laparoscopic",
              "date": "2017-03-22",
              "location": "peritoneal"
            }
          ],
          "diagnoses": [
            {
              "code": "C0025253",
              "label": "Malignant mesothelioma",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Received nine cycles of pemetrexed combined with cisplatin (intravenous injection and abdominal perfusion) since March 2017. Clinical efficacy evaluation in October 2017 suggested disease progression, with increased ascites, local thickening of the peritoneum, and turbidity in the fat space of the mesentery.",
        "timestamp": "2017-10",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0008741",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": "2017-03",
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0976424",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": "2017-03",
              "end_date": null,
              "indication": null
            }
          ],
          "diagnoses": [
            {
              "code": "C0003962",
              "label": "Ascites",
              "status": "active",
              "onset_date": null
            }
          ],
          "imaging": [
            {
              "type": "imaging",
              "body_part": "Peritoneum",
              "modality": null,
              "finding": "thickening",
              "impression": "disease progression",
              "date": "2017-10"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Treatment plan changed to gemcitabine combined with local intra-cavity perfusion. On February 19, 2020, follow-up assessment revealed the peritoneal lesion was larger than before. Gemcitabine chemotherapy was administered for four cycles due to the enlarged peritoneal lesion.",
        "timestamp": "2020-02-19",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0017519",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "Peritoneal lesion"
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "Peritoneal lesion",
              "status": "active",
              "onset_date": null
            }
          ],
          "imaging": [
            {
              "type": null,
              "body_part": "C0031049",
              "modality": null,
              "finding": "enlarged",
              "impression": null,
              "date": "2020-02-19"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Laparoscopic peritoneal mesothelioma resection was performed on May 8, 2020, due to poor efficacy of gemcitabine chemotherapy. Peritoneal lesions were removed, and pathological examination was performed. Gemcitabine chemotherapy was continued twice after surgery.",
        "timestamp": "2020-05-08",
        "clinical_data": {
          "procedures": [
            {
              "name": "Laparoscopic peritoneal mesothelioma resection",
              "approach": "laparoscopic",
              "date": "2020-05-08",
              "location": "peritoneal cavity",
              "outcome": "Peritoneal lesions were removed"
            }
          ],
          "medications": [
            {
              "drug": "gemcitabine",
              "indication": "mesothelioma",
              "start_date": "2020-05-08",
              "end_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "On February 24, 2021, re-examination indicated that the tuberculum of the anterior hepatis was significantly larger than that of October 2020. On March 8, 2021, Laparoscopic peritoneal mesothelioma resection was performed again, and the tuberculum of the anterior hepatis was removed for pathological examination. After surgery, gemcitabine local infusion chemotherapy combined with deep tumor hyperthermia was administered four times.",
        "timestamp": "2021-03-08",
        "clinical_data": {
          "imaging": [
            {
              "type": "tuberculum of the anterior hepatis",
              "body_part": "liver",
              "modality": null,
              "finding": "significantly larger",
              "impression": null,
              "date": "2021-02-24"
            }
          ],
          "procedures": [
            {
              "name": "deep tumor hyperthermia",
              "approach": null,
              "date": null,
              "location": "tumor",
              "performed_by": null,
              "outcome": null
            }
          ],
          "medications": [
            {
              "drug": "Gemcitabine",
              "dosage": null,
              "frequency": null,
              "modality": "local infusion",
              "start_date": null,
              "end_date": null,
              "indication": "mesothelioma"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "In August 2021, a review showed the progression of the disease, and treatment began with immunotherapy combined with hyperthermia and chemotherapy, specifically Camrelizumab combined with Gemcitabine/cisplatin/pemetrexed.",
        "timestamp": "2021-08",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1445743",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2021-08",
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0017167",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2021-08",
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0008833",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2021-08",
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0976423",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": "2021-08",
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0020353",
              "approach": null,
              "date": "2021-08",
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Patient experienced two instances of disease recurrence within 5 years following the initial surgical intervention on May 8",
        "samples": "FFPE-2020 and FFPE-2021). Pathological findings of the two recurrences indicated peritoneal mesothelioma and the immunohistochemical results were consistent with those of the primary lesions. Whole-exome sequencing (300\u00d7) was performed on",
        "clinical_data": {
          "procedures": [
            {
              "name": "Surgical intervention",
              "date": "2024-05-08"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient transitioned from initial presentation with abdominal distension, weakness, and imaging findings of cirrhosis, splenomegaly, portal hypertension, and ascites to a diagnosis of malignant mesothelioma based on laparoscopic peritoneal biopsy and immunohistochemical findings.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0005517"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis",
          "timestamp": "2017-03-22"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Patient underwent nine cycles of pemetrexed and cisplatin chemotherapy following diagnosis of malignant mesothelioma. Disease progressed, with increased ascites, local thickening of the peritoneum, and turbidity in the fat space of the mesentery.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0008741",
            "C0976424"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2017-03"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Due to disease progression on pemetrexed and cisplatin, the treatment plan was changed to gemcitabine. Follow-up assessment revealed the peritoneal lesion was larger than before, and gemcitabine chemotherapy was administered for four cycles.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0017519"
          ],
          "change_type": "addition",
          "target_domain": "medication",
          "timestamp": "2020-02-19"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Due to poor efficacy of gemcitabine chemotherapy, laparoscopic peritoneal mesothelioma resection was performed. Gemcitabine chemotherapy was continued twice after surgery.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0025253"
          ],
          "change_type": "addition",
          "target_domain": "procedure",
          "timestamp": "2020-05-08"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Re-examination indicated that the tuberculum of the anterior hepatis was significantly larger than before. Laparoscopic peritoneal mesothelioma resection was performed again, and the tuberculum of the anterior hepatis was removed for pathological examination. After surgery, gemcitabine local infusion chemotherapy combined with deep tumor hyperthermia was administered four times.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0025253"
          ],
          "change_type": "addition",
          "target_domain": "procedure",
          "timestamp": "2021-03-08"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Review showed the progression of the disease, and treatment began with immunotherapy combined with hyperthermia and chemotherapy, specifically Camrelizumab combined with Gemcitabine/cisplatin/pemetrexed.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1445743",
            "C0017167",
            "C0008833",
            "C0976423"
          ],
          "change_type": "addition"
        }
      }
    }
  ]
}